Lexaria Bioscience Corp. - LEXX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.045M
QoQ value delta ($000)
-$573K (-35.41%)
Implied price effect (QoQ)
-35.08%
Shares
Total shares
1,701,210
QoQ shares delta
-8,837 (-0.52%)
Total shares held by funds (by quarter)

Market chart (LEXX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Invenomic Capital Management LP 290 470,915 0.01%
UBS Group AG 222 361,300 0.0%
VANGUARD GROUP INC 159 258,816 0.0%
GEODE CAPITAL MANAGEMENT, LLC 135 219,718 0.0%
TORONTO DOMINION BANK 86 140,013 0.0%
Byrne Asset Management LLC 65 105,500 0.04%
STATE STREET CORP 24 39,301 0.0%
BlackRock, Inc. 16 27,445 0.0%
Krilogy Financial LLC 15 19,653 0.0%
NORTHERN TRUST CORP 11 18,389 0.0%
RENAISSANCE TECHNOLOGIES LLC 9 15,600 0.0%
BANK OF MONTREAL /CAN/ 8 14,083 0.0%
ROYAL BANK OF CANADA 4 7,283 0.0%
OSAIC HOLDINGS, INC. 1 2,195 0.0%
BANK OF AMERICA CORP /DE/ 0 203 0.0%
MORGAN STANLEY 0 3 0.0%
MAI Capital Management 0 200 0.0%
Tower Research Capital LLC (TRC) 0 32 0.0%
GABLES CAPITAL MANAGEMENT INC. 0 13 0.0%
Farther Finance Advisors, LLC 0 166 0.0%
Federation des caisses Desjardins du Quebec 0 382 0.0%